Rezzayo (as rezafungin acetate) 200 MG Injection

RxCUI: 2639165
RxNorm name: Rezzayo (as rezafungin acetate) 200 MG Injection
Display name: Rezzayo (as rezafungin acetate) 200 MG Injection
Full name: Rezzayo (as rezafungin acetate) 200 MG Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
REZZAYO	REZAFUNGIN	Melinta Therapeutics, LLC	90073508-6dca-4d27-aa5a-ed837737c35b	2026-07-01	Warnings, Adverse reactions	Exact identifier rxcui: 2639165

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
90073508-6dca-4d27-aa5a-ed837737c35b	REZZAYO 200 MG Injection [PSN] · rezafungin 200 MG Injection [Rezzayo] [SBD] · Rezzayo (as rezafungin acetate) 200 MG Injection [SY] · Rezzayo 200 MG Injection [SY]	4	4	These highlights do not include all the information needed to use REZZAYO safely and effectively. See full prescribing information for REZZAYO. REZZAYO ® (rezafungin for injection), for intravenous use Initial U.S. Approval: 2023	20260312